Evexia Lifecare Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

Recent Price Movement and Market Context

On 1 Feb 2026, Evexia Lifecare Ltd’s share price fell by 2.47% during the trading session, closing at Rs.1.5, its lowest level in the past year. This decline came despite a positive opening in the broader market, where the Sensex initially rose by 119.19 points but subsequently reversed sharply, ending the day down 1.88% at 80,722.94 points. The NIFTY FMCG index, which includes edible oil stocks, also hit a 52-week low on the same day, indicating sector-wide headwinds.

The stock has been on a losing streak for two consecutive days, delivering a cumulative negative return of 6.02% over this period. Furthermore, Evexia Lifecare is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling persistent bearish momentum.

Long-Term Performance and Relative Comparison

Over the past year, Evexia Lifecare’s stock price has declined by 47.68%, a stark contrast to the Sensex’s 5.16% gain during the same period. The stock’s 52-week high was Rs.3.3, highlighting the extent of the recent depreciation. This underperformance extends beyond the last year, with the company lagging behind the BSE500 index over one, three years, and the last three months, underscoring a prolonged period of subdued market confidence.

Financial Metrics and Profitability Concerns

Evexia Lifecare’s financial indicators reveal challenges that have contributed to its subdued market valuation. The company has experienced a negative compound annual growth rate (CAGR) of -1.85% in net sales over the last five years, reflecting a contraction in revenue generation. Profitability metrics remain underwhelming, with an average Return on Equity (ROE) of just 0.88%, indicating limited returns on shareholders’ funds.

Recent quarterly results further illustrate the company’s struggles. For the nine months ended September 2025, the Profit After Tax (PAT) stood at Rs.1.31 crore, representing a decline of 66.50% compared to the previous period. The Profit Before Depreciation, Interest and Taxes (PBDIT) for the quarter was Rs.0.11 crore, the lowest recorded in recent times. Operating profit to net sales ratio also dropped to a low of 0.43%, signalling tight margins.

Debt and Valuation Metrics

Debt servicing capacity remains a concern, with the company’s Debt to EBITDA ratio at -1.00 times, indicating a high debt burden relative to earnings before interest, taxes, depreciation, and amortisation. Return on Capital Employed (ROCE) is minimal at 0.1%, while the Enterprise Value to Capital Employed ratio stands at 0.9, suggesting an expensive valuation relative to the company’s capital base despite the stock’s low price.

Compared to its peers, Evexia Lifecare is trading at a discount to average historical valuations, reflecting market caution. Over the past year, profits have declined by 63%, compounding the negative sentiment around the stock.

Shareholding Pattern and Market Position

The majority of Evexia Lifecare’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics. The company operates within the edible oil sector, a segment that has faced volatility due to fluctuating commodity prices and regulatory factors, impacting overall sector performance.

Sector and Market Environment

The edible oil sector has experienced pressure in recent months, with the NIFTY FMCG index hitting a 52-week low alongside Evexia Lifecare’s stock. The broader market environment has been volatile, as evidenced by the Sensex’s sharp reversal after a positive start to the day. The Sensex currently trades below its 50-day moving average, although the 50-day average remains above the 200-day moving average, indicating mixed signals for the market overall.

Evexia Lifecare’s underperformance relative to both the sector and the broader market highlights the specific challenges faced by the company amid a difficult operating landscape.

Summary of Key Performance Indicators

To summarise, Evexia Lifecare Ltd’s stock has reached a 52-week low of Rs.1.5, reflecting a year-long decline of 47.68%. The company’s financial health is characterised by declining sales, reduced profitability, and a high debt burden. Market indicators show the stock trading below all major moving averages, with recent quarterly results underscoring the pressure on earnings and margins. The stock’s valuation metrics suggest a discount relative to peers, yet the overall sentiment remains cautious given the company’s performance trends.

Unlock special upgrade rates for a limited period. Start Saving Now →